Pyridazinone derivatives

US8604036B2 · kind B2 · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Dieter Dorsch · Ober-Ramstadt, DE
• Oliver Schadt · Rodenbach, DE
• Frank Stieber · Heidelberg, DE
• Andree Blaukat · Heilbad Heiligenstadt, DE

Key dates

• Filing date: Mar 24, 2009
• Grant date: Dec 10, 2013
• Expiry date: Nov 5, 2029

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of the formula (I), in which R1, R2, R3, W and D have the meanings indicated in Claim 1, are inhibitors of tyrosine kinases, in particular of Met kinase, and can be employed, inter alia, for the treatment of tumors.